Pro Dex Inc (PDEX) stock
PDEXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 18/3012% below fair value
$61.93−2.55 (-3.95%)
Close on Nov 17, 2026Market cap $198.18MP/E 17.1Yield –
Pro Dex operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Pro Dex's operating cash flow for the twelve months ending Sep 30, 2026 was $11.42M. For fiscal 2026 it was $7.24M. Over ten years it grew 31.6% a year on average. The highest annual figure on record is $7.24M in fiscal 2026.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $7.24M | – |
| FY2025 | Jun 30, 2025 | -$1.68M | -127.0% |
| FY2024 | Jun 30, 2024 | $6.22M | +14.0% |
| FY2023 | Jun 30, 2023 | $5.46M | – |
| FY2022 | Jun 30, 2022 | -$847.00K | – |
| FY2021 | Jun 30, 2021 | -$2.08M | -142.0% |
| FY2020 | Jun 30, 2020 | $4.95M | +48.7% |
| FY2019 | Jun 30, 2019 | $3.33M | +7.4% |
| FY2018 | Jun 30, 2018 | $3.10M | -4.3% |
| FY2017 | Jun 30, 2017 | $3.24M | +594.2% |
| FY2016 | Jun 30, 2016 | $466.00K | – |
| FY2015 | Jun 30, 2015 | -$775.00K | – |
| FY2014 | Jun 30, 2014 | -$329.00K | – |
| FY2013 | Jun 30, 2013 | -$1.27M | -2924.4% |
| FY2012 | Jun 30, 2012 | $45.00K | -98.4% |
| FY2011 | Jun 30, 2011 | $2.90M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $6.49M | +181.0% |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -$273.00K | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $1.63M | +116.6% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $3.57M | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $2.31M | +22.4% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$173.00K | -116.6% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $754.00K | -81.5% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$4.15M | -684.5% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $1.89M | +381.4% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $1.05M | +66.7% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $4.08M | +74.4% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $710.00K | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $392.00K | -86.4% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $627.00K | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $2.34M | +997.7% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$395.00K | -126.0% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $2.89M | +7.1% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$5.28M | -828.1% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $213.00K | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $1.52M | -23.1% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $2.70M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $725.00K | -72.6% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$3.89M | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $1.97M | +19.6% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$888.00K | -197.8% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $2.65M | +998.3% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -$260.00K | -116.5% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $1.65M | +89.2% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $908.00K | +42.8% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $241.00K | -81.6% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $1.58M | +224.5% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $872.00K | +260.3% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $636.00K | -40.1% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $1.31M | -0.6% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $486.00K | -58.1% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $242.00K | -52.1% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $1.06M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $1.32M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $1.16M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $505.00K | – |
See a number that looks wrong?